NewcelX Ltd. (NCEL) is a pharmaceutical preparations company incorporated in Switzerland, listed on the Nasdaq. With a market capitalization of $13 million, NewcelX Ltd. is a micro-cap company. The stock currently trades at $2.87, down 1.03% today, with a 52-week range of $1.89–$30.80.
No 10-K filings found.